Eduard Vilaplana
Madrid, MD 28031, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 03, 2025
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
Journal: JAMA neurology
Published: July 06, 2021
Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults.
Journal: Molecular psychiatry
Published: May 12, 2021
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
Journal: Journal of Alzheimer's disease : JAD
Published: November 30, 2020
AMYQ: An index to standardize quantitative amyloid load across PET tracers.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 30, 2020
Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: May 26, 2020
Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: April 06, 2020
Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome.
Journal: Molecular neurodegeneration
Published: March 05, 2020
Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: February 12, 2020
Last Updated: 09/26/2026